{"corpus_id":90269576,"paper_sha":"6eb6041980c7fc670d4e31df95ce68e661e2bdc4","doi":"10.1002/pro6.5","arxiv_id":null,"pmid":null,"pmcid":null,"mag_id":2579684687,"dblp_id":null,"acl_id":null,"title":"Molecular effectors of radiation resistance in colorectal cancer","year":2017,"publication_date":"2017-03-01","venue":"","journal":{"name":"Precision Radiation Oncology","pages":"27 - 33","volume":"1"},"journal_issn":null,"journal_title":null,"publication_types":[],"pubmed_pub_types":null,"s2_fields_of_study":["Biology","Medicine"],"reference_count":77,"citation_count":20,"influential_citation_count":1,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":null,"chemicals":null,"comments_corrections":null,"source_flags":1,"s2_open_access_pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro6.5","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/6eb6041980c7fc670d4e31df95ce68e661e2bdc4","s2_open_access_license":"CCBYNCND","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Evasion from apoptosis is critical for cancer development and progression. It is also a main reason for the resistance to anticancer therapy. Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer‐related mortality in the USA. Chemotherapy and radiation therapy are often combined with surgery to treat more advanced CRC patients. Although anticancer therapies have yielded a good success rate, the failure of treatment in over 90% of patients with advanced disease is due to resistance to the treatment, one of the biggest obstacles for effective cancer therapy. However, our knowledge of the molecular mechanisms that govern the resistance of CRC is very limited. No significant advance has been made to overcome the resistance. Therefore, there is an urgent need to identify molecules or pathways that can be targeted to overcome the resistance and improve cancer treatment. Expression of phosphatase of regenerating liver‐3 and survivin has been shown to correlate with advanced CRC, liver and lymph node metastases, high risk of recurrences, and worse patient survival. They have been implicated as important effectors in the resistance to anticancer therapy including radiation therapy in CRC. Their potential role in the resistance to radiation therapy makes them promising molecular targets to overcome radioresistance and increase efficacy of radiotherapy. The antagonists against phosphatase of regenerating liver‐3 and survivin could represent a novel type of molecular drug to be used in cancer treatment either as a single agent or, more likely, in combination with radiation or chemoradiation therapy.","claims":[{"public_id":"cl_dcf7d6b2bff059bee7df13e5d0245425","status":"active","text":"Antagonists against phosphatase of regenerating liver-3 and survivin could be used as molecular drugs either alone or in combination with radiation or chemoradiation therapy.","confidence":0.87,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_dcf7d6b2bff059bee7df13e5d0245425"},{"public_id":"cl_5a2249e76e144fba25a67518201a3d30","status":"active","text":"Expression of phosphatase of regenerating liver-3 and survivin correlates with advanced colorectal cancer, metastases, high recurrence risk, and worse patient survival.","confidence":0.93,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_5a2249e76e144fba25a67518201a3d30"},{"public_id":"cl_d5950bc3d0da0aebb9f12023d3b4e528","status":"active","text":"Phosphatase of regenerating liver-3 and survivin are implicated as important effectors of resistance to anticancer therapy, including radiation therapy, in colorectal cancer.","confidence":0.91,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_d5950bc3d0da0aebb9f12023d3b4e528"},{"public_id":"cl_8206008e33509c5511b5d5bf3f090a76","status":"active","text":"Targeting phosphatase of regenerating liver-3 and survivin is presented as a promising strategy to overcome radioresistance and increase radiotherapy efficacy.","confidence":0.9,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_8206008e33509c5511b5d5bf3f090a76"}],"concepts":[{"public_id":"co_3372d1b6cdfa74036f6938ab864b27f2","status":"active","name":"lymph node metastases","description":"Metastatic spread of colorectal cancer to lymph nodes.","types":["metastasis"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3372d1b6cdfa74036f6938ab864b27f2"},{"public_id":"co_479fd5ca6e9ca5bceebf7123a7a29e6d","status":"active","name":"radioresistance","description":"Resistance of cancer cells or tumors to radiation treatment.","types":["treatment resistance"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_479fd5ca6e9ca5bceebf7123a7a29e6d"},{"public_id":"co_59bd9d1aa59d53d69ad1480c89e55a8e","status":"active","name":"antagonists","description":"Agents that inhibit the activity of a molecular target.","types":["drug"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_59bd9d1aa59d53d69ad1480c89e55a8e"},{"public_id":"co_66a62c16f021806302fc8a32f65fa9c4","status":"active","name":"survivin","description":"An inhibitor of apoptosis protein implicated in cancer progression and treatment resistance.","types":["protein"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_66a62c16f021806302fc8a32f65fa9c4"},{"public_id":"co_7c71f3beadfb3499d235b0eeddc01cce","status":"active","name":"advanced colorectal cancer","description":"A later-stage form of colorectal cancer associated with more extensive disease.","types":["cancer stage"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7c71f3beadfb3499d235b0eeddc01cce"},{"public_id":"co_7f8b72f4a3b5272ba53afb15b5bbfa3e","status":"active","name":"colorectal cancer","description":"A malignant disease of the colon or rectum.","types":["cancer"],"aliases":["CRC"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7f8b72f4a3b5272ba53afb15b5bbfa3e"},{"public_id":"co_9f69141356e6e29a4f8f5d4dbd1932b4","status":"active","name":"chemoradiation therapy","description":"A combined treatment approach using chemotherapy and radiation therapy.","types":["therapy"],"aliases":["chemoradiotherapy"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_9f69141356e6e29a4f8f5d4dbd1932b4"},{"public_id":"co_bd4fb4e032163fdd7be9a0a24a08ccc6","status":"active","name":"phosphatase of regenerating liver-3","description":"A protein implicated in colorectal cancer progression and therapy resistance.","types":["protein"],"aliases":["PRL-3"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_bd4fb4e032163fdd7be9a0a24a08ccc6"},{"public_id":"co_c86d56e790a4fb8a4051e4afce52f14d","status":"active","name":"liver metastases","description":"Metastatic spread of colorectal cancer to the liver.","types":["metastasis"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c86d56e790a4fb8a4051e4afce52f14d"},{"public_id":"co_d555458401394b8b1da7cd5eb905e696","status":"active","name":"radiation therapy","description":"Cancer treatment using ionizing radiation.","types":["therapy"],"aliases":["radiotherapy"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d555458401394b8b1da7cd5eb905e696"}],"external_ids":{"DOI":"10.1002/pro6.5","ArXiv":null,"PubMed":null,"PubMedCentral":null,"MAG":2579684687,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro6.5","landing_url":"https://www.semanticscholar.org/paper/6eb6041980c7fc670d4e31df95ce68e661e2bdc4","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBYNCND","status":"GOLD","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":1},"paper_id":638605,"paper_uid":"d98a52db-fb93-4b04-a464-3b09fd1b91a2","canonical_identity":{"paper_id":638605,"paper_uid":"d98a52db-fb93-4b04-a464-3b09fd1b91a2","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/90269576"}